CASI Pharmaceuticals (ENM.STU) Q4 2025 Earnings

14NovConfirmed
Q1 1
Q4 2025
-0.59
-0.48
-0.38
-0.27

Details

Expected EPS
-0.34412
Actual EPS
-0.585004
Surprise EPS
-0.24
Surprise Percent
+70%

Description

CASI Pharmaceuticals (ENM.STU) has reported earnings of -0.585004 per share for Q4 2025.

0 Comments

Share your thoughts